How often does Johnson & Johnson say “Darzalex Faspro” on earnings calls?
Johnson & Johnson said Darzalex Faspro in 2 of the last 5 calls, 3 times in all. Most recently on Tue Oct 13.
Record over the last 5 calls by Johnson & Johnson
Oldest to newest · Oct 14, 2025 – Oct 13, 2026
- Said in
- 2 of 5
- Uses
- 3
- Per call
- 0.6
- Last said
- Oct 13
5 calls counted36 on file
Appearances counted
5 callsOur count of the transcript. Kalshi settles.
| Date | Appearance | Uses | |
|---|---|---|---|
| Q3 2026 earnings callDARZALEX FASPRO 1 | 1 | DARZALEX FASPRO 1 | |
| Q2 2026 earnings call | 0 | none | |
| Q1 2026 earnings callDARZALEX FASPRO 2 | 2 | DARZALEX FASPRO 2 | |
| Q4 2025 earnings call | 0 | none | |
| Q3 2025 earnings call | 0 | none | |
| 10 earlier calls, Apr 2023 – Jul 2025, in Pro | |||
Loading boards
More words Kalshi has listed for Johnson & Johnson
Said in how many of the last 5 calls by Johnson & Johnson
- Ottavasaid in 5 of 5
- Caplytasaid in 5 of 5
- Proceduresaid in 5 of 5
- Tariffsaid in 5 of 5
- Chinasaid in 5 of 5
- Litigationsaid in 4 of 5
- Tecvaylisaid in 3 of 5
- Rybrevantsaid in 2 of 5
- Firefly Biosaid in 2 of 5
- Halda Therapeuticssaid in 2 of 5
- Administrationsaid in 2 of 5
- Nipocalimab / Lupussaid in 1 of 5
Market words from Kalshi · Powered by Kalshi Research (opens in a new tab) · Each count is ours, by the market’s rules: How we count → · A count looks wrong? Report it (email)